1.    Research Framework

1.1. Research Objective

1.2. Phase Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption for the Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

 

4.    Asia-Pacific Clinical Trial Services Industry Insights

 

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Technological Landscape

4.4. Regulatory Framework

4.5. Company market share analysis,2018

4.6. Porter’s Five forces analysis

4.6.1.   Bargaining Power of Suppliers

4.6.2.   Bargaining Power of Buyers

4.6.3.   Threat of New Entrants

4.6.4.   Threat of Substitutes

4.6.5.   Intensity of Rivalry

4.7.PESTEL Analysis

4.8.Strategic Outlook

5.    Asia-Pacific Clinical Trial Services Market Overview

5.1.Market Size & Forecast 2015-2025

5.1.1.   By Value (USD)

5.2.Market Share & Forecast

5.2.1.   By Phase

5.2.1.1.       Phase I

5.2.1.2.       Phase II

5.2.1.3.       Phase III

5.2.1.4.       Phase IV

5.2.2.   By Application

5.2.2.1.       Cancer

5.2.2.2.       Cardiovascular

5.2.2.3.       CNS

5.2.2.4.       Infectious Disease

5.2.2.5.       Metabolic Disease

5.2.2.6.       Others

5.2.3.   By Product

5.2.3.1.       Pharmaceuticals

5.2.3.2.       Biologics

5.2.3.3.       Medical Devices

5.2.3.4.       Others

5.2.4.   By End-User

5.2.4.1.       CRO

5.2.4.2.       Pharmaceutical & Biotech Companies

5.2.5.   By Region

5.2.5.1.       China

5.2.5.2.       Japan

5.2.5.3.       India

5.2.5.4.       Australia

5.2.5.5.       Thailand

5.2.5.6.       Singapore

5.2.5.7.       Indonesia

5.2.5.8.       Rest of Asia-Pacific

6.    Company Profile (Company Overview, Financial Matrix, Key Phase landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

6.1. AQVIA

6.2. Thermo Fisher Scientific Inc.

6.3. Catalent Inc.

6.4. PCI Pharma Services

6.5. Almac Group

6.6. Bionical Ltd

6.7. KLIFO

6.8. Alium Medical Limited

6.9. MYODERM

6.10. Ancillare, LP

6.11. Other Prominent Players

 

List of Figures:

Asia-Pacific Clinical Trial Services Segmentation

Fig: Asia-Pacific Clinical Trial Services Market Value Chain Analysis

Fig: Company Market Share Analysis, 2019

Fig: Asia-Pacific Clinical Trial Services Market Size, By Value (USD Million), 2016-2026

Fig: Asia-Pacific Clinical Trial Services Market Share, By Phase, By Value, 2016-2026

Fig: Asia-Pacific Clinical Trial Services Market Share, By Application, By Value, 2016-2026

Fig: Asia-Pacific Clinical Trial Services Market Share, By Product, By Value, 2016-2026

Fig: Asia-Pacific Clinical Trial Services Market Share, By End-User, By Value, 2016-2026

Fig: Asia-Pacific Clinical Trial Services Market Share, By Region, By Value, 2016-2026

Fig: China Clinical Trial Services Market Size, By Value (USD Million), 2016-2026

Fig: China Clinical Trial Services Market Y-o-Y Growth, By Value, 2017-2026

Fig: China Clinical Trial Services Market Share, By Phase, By Value, 2016-2026

Fig: China Clinical Trial Services Market Share, By Application, By Value, 2016-2026

Fig: China Clinical Trial Services Market Share, By Product, By Value, 2016-2026

Fig: China Clinical Trial Services Market Share, By End-User, By Value, 2016-2026

Fig: China Clinical Trial Services Market Share, By Country, By Value, 2016-2026

Fig: Japan Clinical Trial Services Market Size, By Value (USD Million), 2016-2026

Fig: Japan Clinical Trial Services Market Y-o-Y Growth, By Value, 2017-2026

Fig: Japan Clinical Trial Services Market Share, By Phase, By Value, 2016-2026

Fig: Japan Clinical Trial Services Market Share, By Application, By Value, 2016-2026

Fig: Japan Clinical Trial Services Market Share, By Product, By Value, 2016-2026

Fig: Japan Clinical Trial Services Market Share, By End-User, By Value, 2016-2026

Fig: Japan Clinical Trial Services Market Share, By Country, By Value, 2016-2026

Fig: India Clinical Trial Services Market Size, By Value (USD Million), 2016-2026

Fig: India Clinical Trial Services Market Y-o-Y Growth, By Value, 2017-2026

Fig: India Clinical Trial Services Market Share, By Phase, By Value, 2016-2026

Fig: India Clinical Trial Services Market Share, By Application, By Value, 2016-2026

Fig: India Clinical Trial Services Market Share, By Product, By Value, 2016-2026

Fig: India Clinical Trial Services Market Share, By End-User, By Value, 2016-2026

Fig: India Clinical Trial Services Market Share, By Country, By Value, 2016-2026

Fig: Australia Clinical Trial Services Market Size, By Value (USD Million), 2016-2026

Fig: Australia Clinical Trial Services Market Y-o-Y Growth, By Value, 2017-2026

Fig: Australia Clinical Trial Services Market Share, By Phase, By Value, 2016-2026

Fig: Australia Clinical Trial Services Market Share, By Application, By Value, 2016-2026

Fig: Australia Clinical Trial Services Market Share, By Product, By Value, 2016-2026

Fig: Australia Clinical Trial Services Market Share, By End-User, By Value, 2016-2026

Fig: Australia Clinical Trial Services Market Share, By Country, By Value, 2016-2026

 

*Financial Details will be captured as per data availability in case of unlisted companies

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable.